Correlation Between Eli Lilly and MDxHealth
Can any of the company-specific risk be diversified away by investing in both Eli Lilly and MDxHealth at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eli Lilly and MDxHealth into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eli Lilly and and MDxHealth SA ADR, you can compare the effects of market volatilities on Eli Lilly and MDxHealth and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eli Lilly with a short position of MDxHealth. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eli Lilly and MDxHealth.
Diversification Opportunities for Eli Lilly and MDxHealth
Excellent diversification
The 3 months correlation between Eli and MDxHealth is -0.55. Overlapping area represents the amount of risk that can be diversified away by holding Eli Lilly and and MDxHealth SA ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MDxHealth SA ADR and Eli Lilly is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eli Lilly and are associated (or correlated) with MDxHealth. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MDxHealth SA ADR has no effect on the direction of Eli Lilly i.e., Eli Lilly and MDxHealth go up and down completely randomly.
Pair Corralation between Eli Lilly and MDxHealth
Considering the 90-day investment horizon Eli Lilly and is expected to generate 0.68 times more return on investment than MDxHealth. However, Eli Lilly and is 1.47 times less risky than MDxHealth. It trades about 0.06 of its potential returns per unit of risk. MDxHealth SA ADR is currently generating about -0.23 per unit of risk. If you would invest 77,251 in Eli Lilly and on December 28, 2024 and sell it today you would earn a total of 5,000 from holding Eli Lilly and or generate 6.47% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Eli Lilly and vs. MDxHealth SA ADR
Performance |
Timeline |
Eli Lilly |
MDxHealth SA ADR |
Eli Lilly and MDxHealth Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Eli Lilly and MDxHealth
The main advantage of trading using opposite Eli Lilly and MDxHealth positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eli Lilly position performs unexpectedly, MDxHealth can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MDxHealth will offset losses from the drop in MDxHealth's long position.Eli Lilly vs. Johnson Johnson | Eli Lilly vs. Bristol Myers Squibb | Eli Lilly vs. AbbVie Inc | Eli Lilly vs. Pfizer Inc |
MDxHealth vs. Inozyme Pharma | MDxHealth vs. Day One Biopharmaceuticals | MDxHealth vs. Acumen Pharmaceuticals | MDxHealth vs. Eledon Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Complementary Tools
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
CEOs Directory Screen CEOs from public companies around the world | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |